Amanote Research
Register
Sign In
P.036 Targeted Molecular Therapy With Quinidine for Seizures in a Neonate With KCNT1 Mutation Leads to Poor Response
Canadian Journal of Neurological Sciences
- United Kingdom
doi 10.1017/cjn.2017.121
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Neurology
Date
June 1, 2017
Authors
JM Smith
M Patel
Q Xu
S Uliel-Sibony
M Demos
M Connolly
A Datta
L Looned
Publisher
Cambridge University Press (CUP)
Related search
Migrating Focal Seizures in Autosomal Dominant Sleep-Related Hypermotor Epilepsy With KCNT1 Mutation
Seizure : the journal of the British Epilepsy Association
Medicine
Neurology
Teaching EEG 6 : A Neonate With Suspected Subtle Seizures
International Journal of Epilepsy
Neurology
Recurrent Papillary Craniopharyngioma With BRAFV600E Mutation Treated With Neoadjuvant-Targeted Therapy
Acta Neurochirurgica
Surgery
Neurology
EGFR Mutation: Significance as a Stratification Factor in the Era of Molecular-Targeted Therapy
Oncology Letters
Cancer Research
Oncology
Subgroup Specific Medicine: Finding Patients With Poor Therapy Response
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Corrigendum to “Does Age Affect Response to Quinidine in Patients With KCNT1 Mutations? Report of Three New Cases and Review of the Literature” [Seizure 55 (February) (2018) 1–3]
Seizure : the journal of the British Epilepsy Association
Medicine
Neurology
P101 Intractable Seizures in a Neonate-Case Report
Targeted Molecular Therapy in Glioblastoma
Journal of Oncology
Oncology
Molecular Markers Associated With the Response to Therapy With Everolimus in Patients With Renal Cell Carcinoma
Siberian Journal of Oncology
Cancer Research
Oncology
